Amedi.sk
Dovoľujeme si Vás upozorniť, že naša web stránka
je určená iba pre odbornú lekársku verejnosť.
Časopis Cardiology for practice – Článok Epidemiology of heart failure with preserved ejection fraction. clinical characteristics and comparison with heart failure with reduced ejection fraction

Cardiology for practice

Reviewed, postgraduate scientific medical journal.
Period 4x per year
1336-3433
Free full text. The journal is indexed in the Slovak National Bibliography, Bibliographiia Medica Slovaca (BMS) and listed to citation database CiBaMed. All articles are reviewed. The publisher does not bear any responsibility for data and opinions of particular authors of the articles or advertisements. The articles on grey pages are company promotions or non reviewed information, an author is responsible for the content. Any reproduction of the content is allowed only with direct consent of the editorial office.
Predplatné
Cardiology for practice
Cardiology for practice
Reviewed, postgraduate scientific medical journal.
Period 4x per year
Predplatné
Téma: 

Epidemiology of heart failure with preserved ejection fraction. clinical characteristics and comparison with heart failure with reduced ejection fraction

Katarína Cenkerová, Juraj Dúbrava, Jozef Kalužay, Oľga Jurkovičová

Background: Data related to heart failure with preserved ejection fraction (HFPEF) are limited, even though the prevalence is high and the prognosis is similarly poor in comparison with heart failure with reduced ejection fraction (HFREF). Objective: To examine differences in demographic, clinical, laboratory and ECG characteristics and pre-hospital medication between patients with HFPEF and HFREF. Methods: A total of 228 patients hospitalized in internal department for heart failure (HF) within one year period (2010-2011) were included. All patients were echocardiographically examined. They were divided into two groups based on left ventricular ejection fraction (LVEF); HFPEF with EF > 40 % (n = 117; 51.3 %) and HFREF with LVEF ≤ 40 % (n = 111; 48.7 %). The clinical, biochemical, ECG and echocardiographic data were analysed. Results: A total of 13 % of all hospital admissions were due to HF. Prevalence of HFPEF was 51.3 % and HFREF 48.7 %. Patients with HFPEF were more likely to be female (61 % vs 34 %; p < 0,001), to have arterial hypertension (95 % vs 81 %; p = 0.001), atrial fibrillation (56 % vs 39 %; p < 0.01), obesity (BMI 30.7 vs 27.7; p < 0.01) and oncological disease (18 % vs 8 %; p < 0.05). Patients with HFPEF were significantly older (74.9 vs 69.0 years, p < 0.001) and smaller percentage of them had history of myocardial infarction (42 % vs 26 %; p < 0.05). There was no difference between groups in the prevalence of coronary artery disease (CAD), diabetes mellitus and stroke. Etiology of HFPEF was more frequently associated with arterial hypertension (56 % vs 31 %, p < 0.001), compared to HFREF that was more frequently associated with CAD (44 % vs 80 %; p < 0.001). Systolic and diastolic blood pressure on admission was higher in patients with HFPEF compared to those with HFREF (159.1 vs 136.5 mmHg, resp. 87.8 vs 81.5 mmHg; p < 0,001). Analyses of laboratory parameters showed significantly lower level of NT-proBNP in HFPEF patients (median 4627 vs 6637 ng/l; p < 0.05), worse glomerular filtration rate (0.94 vs 1.07 ml/s; p < 0.05) and lower level of haemoglobin (124 vs 130 g/l; p < 0.05). Patients with HFREF had wider QRS complex (103.7 vs 90.4 ms; p < 0.001) and longer QTc interval (455 vs 427 ms; p < 0.001). There was a nonsignificant trend to higher hospital mortality in HFPEF (8.5 % vs 4.5 %). There was no difference in pre-hospital treatment between the groups. The effective dose of beta-blockers on admission (8 % in HFPEF vs 11 % in HFREF) and at discharge (5 % vs 6 %) was surprisingly very low in both groups. Conclusion: We observed multiple differences in demography, etiology, clinical, biochemical and ECG characteristics between patients with HFPEF and HFREF. We did not identify any significant differences regarding pre-hospital therapy and hospital mortality between the groups.

heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, epidemiology, hospital mortality
Kardiol. Prax 2012; 10 (2): 55-63

Ročník 2012  Témy časopisu Cardiology for practice 2 / 2012

Katarína Cenkerová, Juraj Dúbrava, Jozef Kalužay, Oľga Jurkovičová
Peter Dědič
Ivan Varga, Eva Gonçalvesová
Juraj Dúbrava

Overview works

Ján Kmec
Lucia Jedličková, Lucia Merkovská, Daniel Pella
1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
4 3 2 1
2
Ideal candidate for primary prevention of sudden cardiac death with implantable cardioverter-defibrillator
Cardiac AL Amyloidosis In a 53-year-old Woman
Peripartum Cardiomyopathy
Postablation recurrence of paroxysmal tachycardia – what next?
Left ventricular assist device implantation as a bridge to candidacy (case report)
Pulmonary arteriovenous malformations
Echocardiography in aortic stenosis
STEMI: Possibilities of reperfusion treatment
STEMI management in Slovakia
Kawasaki disease from the cardiologist view
Sudden cardiac death: definition, epidemiology and reality
Patient management after a ICD discharge
Outpatient interventional procedures in cardiology – yes or no?
CHAIRMAN OF THE EDITORIAL BOARD
doc. MUDr. Oľga Jurkovičová, CSc.

CHIEF CONSULTANT
prof. MUDr. Robert Hatala, PhD., FESC

MEMBERS OF THE EDITORIAL BOARD
MUDr. Peter Dědič
MUDr. Juraj Dúbrava, PhD., FESC
MUDr. Viliam Fridrich, PhD.
doc. MUDr. Ján Kmec, PhD.
MUDr. Gabriela Kaliská, PhD., FESC
MUDr. Pavol Lesný
MUDr. Monika Kaldarárová, PhD.
MUDr. Peter Margitfalvi
prof. MUDr. Daniel Pella, PhD.
prof. MUDr. Iveta Šimková, CSc., FESC
MUDr. Viera Vršanská, CSc.

PROFESSIONAL EDITOR
MUDr. Juraj Dúbrava, PhD., FESC

EDITOR-IN-CHIEF
Ing. Danica Paulenová
e-mail: paulenova@amedi.sk

GRAPHIC LAYOUT AND TYPESETTING
Lucia Vecseiová
e-mail: dtp@amedi.sk

MARKETING MANAGER
Ing. Dana Lakotová
mobil: 0903 224 625
e-mail: marketing@amedi.sk

ECONOMY AND SUBSCRIPTIONS
Ing. Mária Štecková
telefón: 02/55 64 72 48
mobil: 0911 117 949
e-mail: ekonom@amedi.sk

LANGUAGE PROOFREADING
Mgr. Eva Doktorová

PROOFREADING OF ENGLISH TEXTS
Mgr. Jana Bábelová
SECTIONS

OVERVIEW PAPERS
The latest knowledge on disease and disease groups aetiology, pathogenesis, diagnoses and therapy. Maximum size is 8 pages (font size 12, line spacing 1.5) with maximum five pictures (graphs). In case of more extensive theme elaboration it is possible to divide the paper to several parts after agreement with editorial office. Write the article with emphasis on its practical usage for cardiologists.

CASE STUDY 
Maximum extent is 7 pages. Structuring: summary, introduction, case study, discussion, conclusion, bibliography.

DIAGNOSTIC AND THERAPEUTICAL ALGORITHMS
Diagnosis and therapy processed into tables and schemes, with minimum text, with emphasis on conciseness and clarity.

MISCELLANEOUS
Reaction to overview articles, news in the field of diagnostics, therapy, trial results (maximum 3 pages), reports from professional events, abstracts from scientific work published abroad, not older than 1 year. Maximum extend is 1 page. Write the title of the paper in Slovak/Czech, authors, workplace, than title of the paper in English with full citation.

FROM BORDERLINE OF CARDIOLOGY
Inter sectional theme elaborated complexly, well-arranged, clear (extent up to 8 pages).


MANUSCRIPT ELABORATION

Write the paper on computer in any common text editor.
- write full length of lines (do not use ENTER at the end of a line)
- do not arrange text into columns
- do not do page make-up, put tables at the end of the paper
- distinguish precisely numbers 1, 0 and letters l, O
- use always parentheses ( )
- explain abbreviations always when first used


MANUSCRIPT REQUIREMENTS

1. An accurate paper title, names and surnames of all authors including academic titles, authors` workplace. The first author address including the phone number, fax and e-mail address.
2. Summary - concise content summary in the extent maximum 10 lines (only at overview papers, case studies from borderline of cardiology). Write in 1st or 3rd person singular or plural (unify according the type of an article).
3. Key words - in the extent of 3-6 (just at overview papers, From borderline of cardiology).
4. English translation: paper title, summary, key words (only at overview papers, case studies and From borderline of cardiology)
5. Text
If you insert pictures into a document, send also their original files in "jpg" format, create graphs in Excel and send also their original files. If you send photo documentation via post office, please, send just high-class originals. Mark each original by a number, under which it is mentioned in the text. Write in 1st or 3rd person singular or plural (unify according the type of an article).
6. Bibliography
Citations are numbered chronologically in bold, references in the text are stated by the number of citations in parentheses. Use maximum 30 citations.

Examples of citations:
1. Shaheen NJ, Crosby NA, Bozymski EM, et al. Is there publication bias in the reporting cancer risk in Barrett´ esophagus? Gastroenterology 2000; 119: 333-338.
2. Stenestrand U, Wallentin L. Swedish Register of Cardiac Intensive Care (RIKS-HIA): Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-436.
3. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
4. Jurkovičová O, Spitzerová H, Cagáň S. Komorové arytmie a náhla srdcová smrť pri akútnom infarkte myokardu. Bratisl Lek Listy 1997; 98: 379-389.
5. Osborne BE. The electrocardiogram of the rat. In: Budden R, Detweiler DK, Zbinden G. The rat electrocardiogram in pharmacology and toxicology. Oxford: Pergamon Press 1981: 15-27.

Do not use dots after first names in citations. Do not use colon but dot after names of authors. Use semi-colon after the year of publishing, colon is before pages. If an author is one, two or three - it is necessary to state all. If there are more than three authors it is necessary to write first three and "et all", in Slovak and Czech citations "a spol."

Due to publishing of autodidactic tests it is necessary to add 4 questions to your article and 4 answers with marking of one correct answer, e.g.:

In which patients, after overcoming of a thromboembolic cerebral or peripheral event, the least suitable catheter closure is foramen ovale patents:
a. a woman before planned pregnancy
b. paroxysmal fibrillation of the atrium
c. aneurysm of the atrium septum
d. origination of an event after cough

The editorial office reserves the right to make small stylistic changes in the paper. If it is necessary to shorten the paper, the consent of the author will be required. All articles are double reviewed.

All published papers are paid.

Due to practical focus of the journal we would like to ask you write the paper comprehensively, with emphasis on practical use of provided information in out-patient practice of cardiologists, internists and other professionals who deal with cardiovascular medicine.

Send contributions in the e-mail to the address: paulenova@amedi.sk
Period 4x per year
1336-3433
Free full text. The journal is indexed in the Slovak National Bibliography, Bibliographiia Medica Slovaca (BMS) and listed to citation database CiBaMed. All articles are reviewed. The publisher does not bear any responsibility for data and opinions of particular authors of the articles or advertisements. The articles on grey pages are company promotions or non reviewed information, an author is responsible for the content. Any reproduction of the content is allowed only with direct consent of the editorial office.
Predplatné
Cardiology for practice
Cardiology for practice
Reviewed, postgraduate scientific medical journal.
Period 4x per year
Predplatné